Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
PIII
HOLDREMOVEP3 Health Partners Inc. · Healthcare · United States · $3.3B · Avg Vol: $31M/d
Value-based healthcare services provider with a very low quality score (Q: 18) and a highly leveraged, unprofitable business model.
COMPANY DESCRIPTION
P3 Health Partners Inc. is a leading physician-led and -managed healthcare company focused on improving health outcomes and reducing costs for Medicare Advantage members. The company operates a capitated, value-based care model, partnering with primary care physicians to manage patient populations. Its competitive advantage stems from its physician-centric approach and ability to deliver cost-effective, coordinated care.
FINANCIAL SUMMARY
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 1.0B | 1.3B | 1.5B | 1.5B | 11.6% |
| EPS | -325.00 | -30.50 | -47.00 | -45.26 | — |
| Shares | 831,577 | 2M | 3M | 3M | +295.2% |
| Debt | 106M | 122M | 195M | 285M | 39.1% |
| Equity | 6M | 142M | 76M | -155M | 260.2% |
| Op CF | -126M | -76M | -110M | -91M | — |
| Inv CF | -8M | -2M | 15M | 129,000 | — |
| Fin CF | 11M | 100M | 99M | 73M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of PIII are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| PIII | P3 Health Partners Inc.(you) | $3.3B | 37 | HOLD |
| BKD | Brookdale Senior Living Inc. | $3.1B | 57 | HOLD |
| OPCH | Option Care Health, Inc. | $3.4B | 60 | HOLD |
| SGRY | Surgery Partners, Inc. | $1.8B | 57 | HOLD |
| ACHC | Acadia Healthcare Company, Inc. | $2.2B | 66 | BUY |
| USPH | U.S. Physical Therapy, Inc. | $972M | 54 | HOLD |
| ENSG | The Ensign Group, Inc. | $10.0B | 57 | HOLD |
| AGL | agilon health, inc. | $1.5B | 65 | HOLD |
| GMRS | GMR Solutions Inc. | $676M | 51 | HOLD |
| PNTG | The Pennant Group, Inc. | $1.2B | 68 | BUY |
Peer medians: ROE -21.9% · P/E 25.1x · Gross margin 44.3%